2-chloro-n(6)cyclopentyladenosine has been researched along with uric acid in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
---|---|---|---|---|---|
252 | 0 | 43 | 27,980 | 1,717 | 9,982 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | uric acid (IC50) |
---|---|---|---|
Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardenheuer, HJ; Heller, AR; Koch, T; Plaschke, K; Rothermel, J; Schmeck, J; Weigand, MA; Wendel, M | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and uric acid
Article | Year |
---|---|
Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine Diphosphate; Adenosine Triphosphate; Analysis of Variance; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Disease Models, Animal; Endotoxemia; Endotoxins; Energy Metabolism; Female; Lipopolysaccharides; Lung; Pulmonary Artery; Pulmonary Edema; Rabbits; Receptors, Purinergic P1; Respiratory Distress Syndrome; Time Factors; Uric Acid; Vasoconstriction | 2007 |